Cargando…

MON-LB83 The Initial Dose of (131)I as a Potential Independent Predictor for Residual/Relapsed Disease in Pediatric Differentiated Thyroid Cancer

Introduction: In the guidelines for management of pediatric Differentiated Thyroid Cancer (DTC) (131)I therapy is recommended for treatment of iodine-avid persistent locoregional disease that cannot be resected as well as iodine-avid distant metastases. To date, no consensus has been reached regardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bustamante Escobar, Carmen L, Bao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209508/
http://dx.doi.org/10.1210/jendso/bvaa046.2179

Ejemplares similares